Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Osteoporosis in Men
NCT00097825Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Aug 2007
- Countries
- 3
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis, sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00097825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097825.